Interestingly, a recent study showed that a synthetic ligand that activates NR4A2 is neuroprotective in a mouse model of MPTP-Induced Parkinsonism, suppressing loss of dopaminergic neurons in the substantia nigra pars compacta and DA terminals in the striatum64. This evidence concerns the gene NR4A2 and Parkinsonism.